Chemed Corporation (NYSE:CHE) Receives Average Recommendation of “Hold” from Brokerages

Chemed Corporation (NYSE:CHE) has earned an average recommendation of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $498.00.

Several brokerages have issued reports on CHE. Oppenheimer cut their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group cut Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd.

Chemed Price Performance

CHE opened at $371.46 on Friday. Chemed has a 12-month low of $368.44 and a 12-month high of $623.60. The stock has a market capitalization of $5.11 billion, a PE ratio of 20.22, a P/E/G ratio of 1.48 and a beta of 0.46. The firm’s fifty day moving average price is $429.83 and its 200 day moving average price is $436.19.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The company had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. During the same period in the previous year, the firm posted $6.83 EPS. Chemed’s revenue for the quarter was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, equities research analysts forecast that Chemed will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is presently 13.06%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the sale, the chief executive officer owned 93,719 shares of the company’s stock, valued at $37,785,626.42. This represents a 2.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.29% of the company’s stock.

Hedge Funds Weigh In On Chemed

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. raised its position in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after purchasing an additional 5,549,876 shares during the period. JPMorgan Chase & Co. increased its position in Chemed by 4.4% in the fourth quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock worth $223,301,000 after buying an additional 21,932 shares during the period. William Blair Investment Management LLC lifted its stake in Chemed by 13.6% in the third quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock valued at $172,435,000 after buying an additional 46,038 shares during the last quarter. AQR Capital Management LLC lifted its stake in Chemed by 89.2% in the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after buying an additional 153,469 shares during the last quarter. Finally, TD Asset Management Inc boosted its holdings in shares of Chemed by 7.5% during the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after acquiring an additional 22,715 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.